Skip to main content
. 2007 May 8;96(11):1723–1728. doi: 10.1038/sj.bjc.6603785

Figure 2.

Figure 2

VEGFR1 expression with or without metastasis and recurrence. There is no significant difference between patients with metastasis at the time of operation and patients with postoperative recurrence. The higher VEGFR1 expression was observed in patients with metastasis pre- and postoperatively in comparison with gastric cancer patients without metastasis (P<0.0001, respectively).